[Cerebral toxoplasmosis in an anti-HIV positive man]

Immunogenicity and safety of rapid scheme vaccination against tick-borne encephalitis in HIV-1 infected persons.

Epidemiology and infection·2021

Prevalence and the role of CCR5Δ32 heterozygosity in disease progression in HIV positive patients in the Czech Republic

Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne·2020

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens.

HIV medicine·2017

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2015

Incidence, immunological and clinical characteristics of reactivation of latent Toxoplasma gondii infection in HIV-infected patients.

Epidemiology and infection·2014

[Guidelines for caring for HIV-infected adults and postexposure prophylaxis for HIV infection].

Klinicka mikrobiologie a infekcni lekarstvi·2013

[Growth, development and prediction of body height in children with central precocious puberty after 3 years of therapy with Decapeptyl-Depot, a slow-releasing GnRH agonist].

Ceskoslovenska pediatrie·1994

[Dangers in external treatment of skin diseases in childhood].

Ceskoslovenska pediatrie·1994

[The effect of growth hormone therapy on thyroid parameters].

Ceskoslovenska pediatrie·1994

[Long-term therapy of central precocious puberty in girls with the gonadoliberin analog D-Trp-6-LHRH after prior therapy with cyproterone acetate].

Ceskoslovenska pediatrie·1994

[Improvement in the prognosis for growth in a boy with central precocious puberty and growth hormone deficiency treated concurrently with growth hormone and D-Trp-6-LHRH gonadoliberin analog].

Ceskoslovenska pediatrie·1994

[D-Trp-6 gonadotropin analog releasing hormone (Decapeptyl-Depot)-- the drug of choice in central idiopathic precocious puberty].

Ceskoslovenska pediatrie·1994

The spatial architecture of tumor immunity: Emerging predictive biomarkers across cancer.

Immunologic research·2026

Inflammatory Soft Tissue Tumors: A Wolf in Sheep's Clothing.

Archives of pathology & laboratory medicine·2026

Usefulness of 20-mm incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma: a single-center experience.

Leukemia & lymphoma·2026

ITPRIPL1: A tumor immune-associated biomarker with prognostic and therapeutic implications in gastrointestinal cancer.

Scientific reports·2026

Differential effects of BCG-Russia and BCG-TICE on trained immunity: Potential implications for bladder cancer immunotherapy.

PloS one·2026

Spatial statistics infer structured immune signatures in primary prostate cancer.

Cancer immunology research·2026

Related Experiment Videos

[Cerebral toxoplasmosis in an anti-HIV positive man]

Related Concept Videos

Immunogenicity and safety of rapid scheme vaccination against tick-borne encephalitis in HIV-1 infected persons.

Prevalence and the role of CCR5Δ32 heterozygosity in disease progression in HIV positive patients in the Czech Republic

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Incidence, immunological and clinical characteristics of reactivation of latent Toxoplasma gondii infection in HIV-infected patients.

[Guidelines for caring for HIV-infected adults and postexposure prophylaxis for HIV infection].

[Growth, development and prediction of body height in children with central precocious puberty after 3 years of therapy with Decapeptyl-Depot, a slow-releasing GnRH agonist].

[Dangers in external treatment of skin diseases in childhood].

[The effect of growth hormone therapy on thyroid parameters].

[Long-term therapy of central precocious puberty in girls with the gonadoliberin analog D-Trp-6-LHRH after prior therapy with cyproterone acetate].

[Improvement in the prognosis for growth in a boy with central precocious puberty and growth hormone deficiency treated concurrently with growth hormone and D-Trp-6-LHRH gonadoliberin analog].

[D-Trp-6 gonadotropin analog releasing hormone (Decapeptyl-Depot)-- the drug of choice in central idiopathic precocious puberty].

The spatial architecture of tumor immunity: Emerging predictive biomarkers across cancer.

Inflammatory Soft Tissue Tumors: A Wolf in Sheep's Clothing.

Usefulness of 20-mm incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma: a single-center experience.

ITPRIPL1: A tumor immune-associated biomarker with prognostic and therapeutic implications in gastrointestinal cancer.

Differential effects of BCG-Russia and BCG-TICE on trained immunity: Potential implications for bladder cancer immunotherapy.

Spatial statistics infer structured immune signatures in primary prostate cancer.

Related Experiment Videos

[Cerebral toxoplasmosis in an anti-HIV positive man]

Related Concept Videos

Related Articles